Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001738995-18-000003
Filing Date
2018-12-03
Accepted
2018-12-03 14:58:06
Documents
1
Effectiveness Date
2018-12-03
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6472
  Complete submission text file 0001738995-18-000003.txt   7533
Mailing Address 1928 OLD MIDDLEFIELD WAY, SUITE B MOUNTAIN VIEW CA 94043
Business Address 1928 OLD MIDDLEFIELD WAY, SUITE B MOUNTAIN VIEW CA 94043 650-248-7914
Tulavi Therapeutics, Inc. (Filer) CIK: 0001738995 (see all company filings)

EIN.: 824929716 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-311235 | Film No.: 181213800